about
Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activityThe Pathophysiology of Moyamoya Disease: An UpdateRole of CX3CR1 receptor in monocyte/macrophage driven neovascularizationHuman umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivoVasculogenesis: a new piece of the endometriosis puzzleA subset of cerebrovascular pericytes originates from mature macrophages in the very early phase of vascular development in CNS.CD34⁺/M-cadherin⁺ bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE⁻/⁻ mice.Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expressionComparative angiogenic activities of induced pluripotent stem cells derived from young and old mice.The secretome of endothelial progenitor cells promotes brain endothelial cell activity through PI3-kinase and MAP-kinase.Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes.Bioengineering heart muscle: a paradigm for regenerative medicineRepertoire of endothelial progenitor cells mobilized by femoral artery ligation: a nonhuman primate studyAnalysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration.Hypoxic preconditioning-induced autophagy enhances survival of engrafted endothelial progenitor cells in ischaemic limb.Omental grafting: a cell-based therapy for blood vessel repair.Modulating the vascular response to limb ischemia: angiogenic and cell therapies.Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network FormationExperimental acute myocardial infarction: telocytes involvement in neo-angiogenesis.Cell therapy of peripheral arterial disease: from experimental findings to clinical trials.Echocardiographic evaluation of the effects of stem cell therapy on perfusion and function in ischemic cardiomyopathy.Towards the therapeutic use of vascular smooth muscle progenitor cells.Umbilical cord blood for cardiovascular cell therapy: from promise to fact.Angiogenesis in the infarcted myocardium.Smooth muscle cells and the formation, degeneration, and rupture of saccular intracranial aneurysm wall--a review of current pathophysiological knowledge.Cell-based therapies for cardiac disease: a cellular therapist's perspective.A Novel Selectable Islet 1 Positive Progenitor Cell Reprogrammed to Expandable and Functional Smooth Muscle Cells.Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.The injury theory, endothelial progenitors, and sleep apnea.Autophagy in endothelial progenitor cells is cytoprotective in hypoxic conditions.Biofunctionalized quantum dots for live monitoring of stem cells: applications in regenerative medicine.Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb.Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia.Correlation between Therapeutic Efficacy of CD34+ Cell Treatment and Directed In Vivo Angiogenesis in Patients with End-Stage Diffuse Coronary Artery Disease.Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach.Purified CD34 cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trialDevelopment of Bioactive Patch for Maintenance of Implanted Cells at the Myocardial Infarcted Site
P2860
Q24321699-E8006FD5-38C4-4923-9D5C-C84D562B9287Q26769012-284D0353-BAC1-4218-8B82-A5726D29123BQ27313463-ECE674BB-0B60-4AC4-BA8C-7E533044C50FQ27336125-6D5874E0-8FA5-4671-B04C-BA30CCD9F953Q28237930-C236BA87-D835-4E15-B315-018F882E9464Q33818780-68156260-7C66-48EC-A395-03D1395B86EAQ33934035-428E4641-E5BD-4134-8105-BAF265E53525Q33999277-80A3579B-9D01-41E3-BC9B-952A5CB9A745Q34326261-07F4824F-FED2-4D5C-A456-838547F82F66Q35154977-0019C21B-2586-4571-9DEA-01BDB6FDC7A3Q36109260-A67C3ABD-D260-4F56-9873-9566CDB01DD1Q36117532-6857A2E7-8FBF-4D8B-8C8E-C9986A5E0D64Q36208786-4D39FA93-754F-4BE4-AEFA-10E631C179ACQ36280879-795AA097-596E-4E88-9A5C-3857B4DD1F2FQ36333615-F43BB713-D183-40B8-9866-E255EC96C32DQ36901724-B2956837-F873-45E5-A36F-906FA29930E0Q36908997-5E2011EE-07FE-48C7-BB8D-BA07CB58B523Q36920724-CC80A719-BC72-4247-933E-48EC1960BDCBQ37042648-DB14EE6F-5E1C-400D-888F-9293075E4490Q37294834-EA714EE5-5B3A-4F00-A89A-FB8C3CDB8177Q37338896-69EC8FB3-B97B-48DE-B629-FC98599BA418Q37625091-3FDAA0DC-2933-4F60-8691-E02D1B68CC73Q37987098-25BCAE34-81DC-419A-A9EF-9AF23805AE7BQ38006735-4CFB9A30-7EE6-4021-B011-FF7672EBE741Q38032602-D515B9FA-17E8-4F5D-B0B9-39188A3CB987Q38200573-21E6D1F5-1A3E-42F8-85D5-671E571AB2DFQ38241994-94E24BCF-313E-4C60-9C94-FB642FAF9FD9Q38912649-C1B09855-421E-4843-AD91-6344E42347F0Q42292968-3C1DB682-EC0A-4F72-9793-A1D2EA8659FDQ43249085-051E6901-6A4C-499B-838E-B93AD90950C2Q43999462-763F56E2-D252-4B9D-9022-F8DE51AF58EDQ49168851-705D06C6-DA55-4BC3-A29D-457558DE3D26Q50797309-9BE33722-6EB3-4847-878D-E338A45683F8Q51161546-4271B035-7487-41CB-A50E-1A9639366D4AQ53859054-B97DD551-0B9E-4329-8FE8-4188B60EE059Q54226589-725C81EF-8EA2-454A-9A2D-E2351A4CE873Q58693006-F6A524AC-5F29-4F4B-BC1A-08DDCE0B829FQ59113673-B50E6D1D-0604-4BB8-93AA-C200D48FFC25
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical potential of adult vascular progenitor cells.
@en
Clinical potential of adult vascular progenitor cells.
@nl
type
label
Clinical potential of adult vascular progenitor cells.
@en
Clinical potential of adult vascular progenitor cells.
@nl
prefLabel
Clinical potential of adult vascular progenitor cells.
@en
Clinical potential of adult vascular progenitor cells.
@nl
P1476
Clinical potential of adult vascular progenitor cells
@en
P2093
Arun H S Kumar
P304
P356
10.1161/ATVBAHA.109.198895
P407
P50
P577
2010-05-07T00:00:00Z